l'Aster
ActiveSummary
l'Aster has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €657,411 and a net result of -€33,840. Equity is growing by ~5.1% per year across the filed fiscal years. Its solvency ranks better than 82% of 644 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability13▲+3
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45,000 at 30 days acceptable
Liquidity ample (current ratio 4.4 against 4.36 in 2024; short-term debt: 16.6% and cash: 10.2% of total assets), and 16.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
83.4%
Return on assets
-4.3%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€33,840
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
28 d late
2024
28 d early
2023
119 d late
2022
29 d late
2021
85 d late
2020
157 d late
2019
123 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 73 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 29 August (4 of the last 5 filed years within 57 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€33,840▲ 44.7%
2024 · -€61,244
Working capital
€445,333▼ 9.8%
2024 · €493,681
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€119,201▲ 738%€60,871▼ 48.9%€18,032▼ 70.4%-€61,237-€36,007▲ 41.2%
Net result€116,673within the sector's middle half▲ 1,144%€58,418within the sector's middle half▼ 49.9%€16,277within the sector's middle half▼ 72.1%-€61,244below the sector's middle half-€33,840below the sector's middle half▲ 44.7%
Equity€677,800above the sector's middle half▲ 20.8%€736,218within the sector's middle half▲ 8.6%€752,495within the sector's middle half▲ 2.2%€691,251within the sector's middle half▼ 8.1%€657,411within the sector's middle half▼ 4.9%
Total assets€888,315within the sector's middle half▲ 7.6%€920,908within the sector's middle half▲ 3.7%€906,962within the sector's middle half▼ 1.5%€837,985within the sector's middle half▼ 7.6%€788,511within the sector's middle half▼ 5.9%
Debt€210,515▼ 20.3%€184,690▼ 12.3%€154,467▼ 16.4%€146,734▼ 5.0%€131,100▼ 10.7%
Working capital€539,085above the sector's middle half▲ 21.7%€575,963above the sector's middle half▲ 6.8%€559,107above the sector's middle half▼ 2.9%€493,681within the sector's middle half▼ 11.7%€445,333within the sector's middle half▼ 9.8%
Solvency76.3%above the sector's middle half▲ 8.3pp79.9%above the sector's middle half▲ 3.6pp83.0%above the sector's middle half▲ 3.0pp82.5%above the sector's middle half▼ 0.5pp83.4%above the sector's middle half▲ 0.9pp
Current ratio5.31above the sector's middle half▲ 1.275.37above the sector's middle half▲ 0.065.14above the sector's middle half▼ 0.224.36within the sector's middle half▼ 0.784.40within the sector's middle half▲ 0.03
Return on assets (ROA)13.1%within the sector's middle half▲ 12.0pp6.3%within the sector's middle half▼ 6.8pp1.8%below the sector's middle half▼ 4.5pp-7.3%below the sector's middle half▼ 9.1pp-4.3%below the sector's middle half▲ 3.0pp
Staff (FTE)8.1within the sector's middle half▲ 1.3%7.3within the sector's middle half▼ 9.9%6.5within the sector's middle half▼ 11.0%7within the sector's middle half▲ 7.7%6.4within the sector's middle half▼ 8.6%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €36,007 in 2025 against €61,237 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €788,511
Fixed assets
€212,093 ▲ 7.3%
Current assets
€576,418 ▼ 10.0%
Equity and liabilities €788,511
Equity
€657,411 ▼ 4.9%
Debt
€131,100 ▼ 10.7%
Debt's share of the balance-sheet total falls from 17.5% to 16.6%. Equity and debt are lower.
Key figures and ratios
EBITDA
-€11,250▲
2024 · -€44,276
Cash flow
-€9,083▲
2024 · -€44,283
Debt to equity
0.20▼
2024 · 0.21
ROE
-5.1%▲
2024 · -8.9%
Interest coverage
-6.27▲
2024 · -11.84
Debt ≤ 1 year
€131,085▼
2024 · €146,719
Staff costs
€508,744▼
2024 · €534,065
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 12,321 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 90% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a small loss
0.7%
went bankrupt
8.6%
stopped otherwise
90%
still going
A further 0.5% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 12,321 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €419,438 | €428,053 | €445,058 | €534,065 | €508,744 | ▼ 4.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €15,305 | €17,559 | €17,657 | €16,960 | €24,757 | ▲ 46.0% |
| Other operating charges640/8 | - | - | - | - | €18,562 | - |
| Operating charges capitalised as restructuring costs649 | - | - | - | - | €0 | - |
| Gross operating margin9900 | €553,944 | €506,483 | €480,747 | €489,789 | €516,056 | ▲ 5.4% |
| Operating profit (loss)9901 | €119,201 | €60,871 | €18,032 | -€61,237 | -€36,007 | ▲ 41.2% |
| Financial income75/76B | €1,026 | €72 | €1,811 | €3,733 | €3,960 | ▲ 6.1% |
| Recurring financial income75 | €1,026 | €72 | €1,811 | €3,733 | €3,960 | ▲ 6.1% |
| Financial charges65/66B | €3,554 | €2,525 | €3,566 | €3,740 | €1,793 | ▼ 52.0% |
| Recurring financial charges65 | €3,554 | €2,525 | €3,566 | €3,740 | €1,793 | ▼ 52.0% |
| Profit (loss) for the period before taxes9903 | €116,673 | €58,418 | €16,277 | -€61,244 | -€33,840 | ▲ 44.7% |
| Profit (loss) for the period9904 | €116,673 | €58,418 | €16,277 | -€61,244 | -€33,840 | ▲ 44.7% |
| Profit (loss) for the period to be appropriated9905 | €116,673 | €58,418 | €16,277 | -€61,244 | -€33,840 | ▲ 44.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €888,315 | €920,908 | €906,962 | €837,985 | €788,511 | ▼ 5.9% |
| Fixed assets21/28 | €224,238 | €213,092 | €212,956 | €197,585 | €212,093 | ▲ 7.3% |
| Tangible fixed assets22/27 | €224,238 | €213,092 | €212,956 | €197,585 | €212,093 | ▲ 7.3% |
| Land and buildings22 | €219,296 | €212,179 | €210,965 | €196,641 | €203,701 | ▲ 3.6% |
| Furniture and vehicles24 | €4,942 | €913 | €1,991 | €944 | €8,392 | ▲ 789% |
| Current assets29/58 | €664,077 | €707,816 | €694,006 | €640,400 | €576,418 | ▼ 10.0% |
| Amounts receivable within one year40/41 | €86,636 | €90,313 | €84,195 | €86,925 | €91,560 | ▲ 5.3% |
| Trade receivables40 | €53,720 | €48,974 | €46,961 | €1,304 | - | - |
| Other amounts receivable41 | €32,916 | €41,339 | €37,234 | €85,622 | €91,560 | ▲ 6.9% |
| Current investments50/53 | €204,517 | €361,517 | €412,515 | €415,010 | €402,436 | ▼ 3.0% |
| Cash at bank and in hand54/58 | €369,678 | €252,650 | €196,422 | €134,634 | €80,552 | ▼ 40.2% |
| Deferred charges and accrued income490/1 | €3,246 | €3,336 | €874 | €3,830 | €1,871 | ▼ 51.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €888,315 | €920,908 | €906,962 | €837,985 | €788,511 | ▼ 5.9% |
| Equity10/15 | €677,800 | €736,218 | €752,495 | €691,251 | €657,411 | ▼ 4.9% |
| Reserves13 | €273,000 | €323,000 | €323,000 | €293,000 | €263,000 | ▼ 10.2% |
| Profit (loss) carried forward14 | €404,800 | €413,218 | €429,495 | €398,251 | €394,411 | ▼ 1.0% |
| Amounts payable17/49 | €210,515 | €184,690 | €154,467 | €146,734 | €131,100 | ▼ 10.7% |
| Amounts payable after more than one year17 | €85,514 | €52,828 | €19,321 | - | - | - |
| Financial debts170/4 | €85,514 | €52,828 | €19,321 | - | - | - |
| Amounts payable within one year42/48 | €124,992 | €131,853 | €134,899 | €146,719 | €131,085 | ▼ 10.7% |
| Current portion of amounts payable after more than one year42 | €31,886 | €32,686 | €33,507 | €19,322 | - | - |
| Trade debts44 | €40,870 | €31,556 | €47,421 | €49,213 | €66,230 | ▲ 34.6% |
| Suppliers440/4 | €40,870 | €31,556 | €47,421 | €49,213 | €66,230 | ▲ 34.6% |
| Taxes, remuneration and social security45 | €50,676 | €67,611 | €51,509 | €75,723 | €62,394 | ▼ 17.6% |
| Taxes450/3 | €11,911 | €9,477 | €3,338 | €12,141 | €44 | ▼ 99.6% |
| Remuneration and social security454/9 | €38,765 | €58,134 | €48,171 | €63,582 | €62,349 | ▼ 1.9% |
| Accrued charges and deferred income492/3 | €9 | €9 | €247 | €15 | €15 | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €116,673 | €58,418 | €16,277 | -€61,244 | -€33,840 | ▲ 44.7% |
| + Depreciation and write-downs630 | €15,305 | €17,559 | €17,657 | €16,960 | €24,757 | ▲ 46.0% |
| Operating cash flow (approximation) | €131,978 | €75,977 | €33,934 | -€44,283 | -€9,083 | ▲ 79.5% |
| Investment in fixed assets (approximation) | - | -€6,413 | -€17,521 | -€1,590 | -€39,265 | ▼ 2,370% |
| Change in cash | - | -€117,028 | -€56,228 | -€61,788 | -€54,082 | ▲ 12.5% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 28 days late
19-08
State Gazette act
Resignations: Linda Hakoua (administrateur.trice) and Fabrice Vast (administrateur.trice)Appointments: Lydia (administrateur.trice) and Yousra (administrateur.trice) · Power of attorney9 facts ▸
State Gazette act
Resignations: Linda Hakoua (administrateur.trice) and Fabrice Vast (administrateur.trice)
Appointments: Lydia (administrateur.trice) and Yousra (administrateur.trice) · Power of attorney9 facts ▸
- General meeting, 21-05-2026
- Director resignation, Linda Hakoua (administrateur.trice)
- Director resignation, Fabrice Vast (administrateur.trice)
- Director in office, Tim (administrateur.trice)
- Director in office, Bernard (administrateur.trice)
- Director appointment, Lydia (administrateur.trice)
- Director appointment, Yousra (administrateur.trice)
- Power of attorney, J.Jordens SRL
- Power of attorney, Serge Solau
2025
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet -€61,244
Net result drops to -€61,244, the lowest in the series; recovery starts the following year.
27-11
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 119 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 29 days late
2022
24-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 85 days late
04-01
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 157 days late
2021
31-12
Financial
Highest result since 2018net €116,673 ▲1,144%
Operating result €119,201, net result €116,673, both a record.
2020
01-12
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 123 days late
2019
31-12
Financial
Equity above €500,000Eq €551,747 ▲14.6%
2 profitable years in a row build equity to €551,747.
28-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 28 days late
2018
13-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 13 days late
2017
24-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 21 acts read
About the unread acts
Of the 21 Belgian State Gazette acts we know for this company, 1 has been read. The other 20 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 directors, last change in 2026
Lydia
CurrentAdministrateur.trice · since 19-08-2026
Yousra
CurrentAdministrateur.trice · since 19-08-2026
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
20 of this company's 21 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2003
Ground area
219 m²
Building footprint
105 m²
Volume, LiDAR
711 m³
Parcel 21903B0505/00V003, Brussels · tallest building 12.9 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
'Aster
since 20032.179.072.534
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21903B0505/00V003 | Brussels | 219 m² | 1 · 105 m² | 12.9 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
4 people since 2026, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Lydia |
|
| Yousra |
|
| Fabrice Vast |
|
| Hakoua Linda |
|
Articles of association
Board rule
One provision in the deed
Structure & network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Similar companies · same sector, comparable size
Medisch Kabinet Dr. Van Belle Gunther
BE 0718.932.425
Sint-Pieters-Leeuw · Eq €657,649
Dr. Kurt Fonteyne, huisarts
BE 0831.865.466
Wortegem-Petegem · Eq €658,349
VALMORELLE MEDICALE
BE 0840.706.819
Momignies · Eq €656,412
MAISON MEDICALE 1190
BE 0839.558.754
Vorst · Eq €658,454
DR. ST. BRESSELEERS
BE 0468.885.033
Wijnegem · Eq €658,630
Of 9,130 companies in sector 86210 we hold annual accounts for 6,336. 4,639 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formNon-profit association
Founded20-01-1995
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Contact
Phone
02 216 12 62
Fax
02 242 32 75
E-invoicing
Not found in the Peppol register
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance
If you follow this company, Checked tells you the day it appears in the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.